Swissinfo: Can Novartis’s sustainability-linked bond make good on its promises?

In a long-read for Swissinfo, Jessica Davis Plüss explores different viewpoints on the sustainability-linked bond launched by the Swiss pharmaceutical company Novartis.

The Access to Medicine Foundation gave a second-party opinion on Novartis's sustainability-linked bond (SLB), which was launched in September 2020. As part of her news feature, Jessica interviewed the Foundation's Director of Operations and Research, Marijn Verhoef, to explore the question of what metrics are suitable to include as part of SLBs,

“There's no one golden standard for a KPI [key performance indicator] that companies can apply," Marijn explained. However, as he pointed out, it is a step forward that investors are becoming part of the global health discussion.

Read the full article on the SwissInfo website.